Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Octopus Aim Share Price
  4. Octopus Aim Share Regulatory News
  5. Holding(s) in Company

Pin to quick picksOctopus Aim Regulatory News (OOA)

Octopus Aim Information

Share Price Information for Octopus Aim (OOA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.50
Bid: 60.00
Ask: 63.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.00%)
Open: 61.50
High: 61.50
Low: 61.50
Prev. Close: 61.50
OOA Live PriceLast checked at -
Octopus AIM VCT is an Investment Trust

To invest in a broad range of AIM or NEX Exchange traded companies in order to provide shareholders with attractive tax-free dividends and long-term capital growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

15 Aug 2008 18:27

RNS Number : 4874B
IS Pharma PLC
15 August 2008
 



IS Pharma plc

('IS Pharma' or the 'Company')

Notification of Interest

The Company was informed on 5 August 2008 that Close Investments Limited had a notifiable interest of 397,090 ordinary shares in IS Pharma, being 1.29% of the issued share capital of the Company. 

The change in notifiable interest follows the transfer of the three Close Brothers' AIM VCTs (Close Brothers AIM VCT, Close Second AIM VCT and Close IHT AIM VCT) to Octopus Investments Limited. Subsequent to this transfer Close Investments Limited no longer has a notifiable interest in ordinary 70 pence shares of IS Pharma. 

For further information, please call:

Financial Dynamics Limited  +44(0) 20 7831 3113

Billy Clegg / Edward Westropp

Noble & Company Limited  +44(0) 20 7763 2200

Matthew Hall / Sam Reynolds

IS Pharma +44(0) 1244 625150

Tim Wright, CEO

www.ispharma.plc.uk 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLILFLDTVIELIT
34567891011
Date   Source Headline
20th May 20216:10 pmGNWTransaction in Own Shares
19th May 20211:44 pmGNWNet Asset Value(s)
13th May 20216:40 pmGNWNet Asset Value(s)
12th May 20213:39 pmGNWNet Asset Value(s)
28th Apr 20216:51 pmGNWNet Asset Value(s)
22nd Apr 20215:34 pmGNWTransaction in Own Shares and Total Voting Rights
21st Apr 20211:24 pmGNWNet Asset Value(s)
16th Apr 20217:00 amGNWIssue of Equity
13th Apr 20216:45 pmGNWNet Asset Value(s)
13th Apr 20211:02 pmGNWNet Asset Value(s)
12th Apr 20217:52 amGNWDirector Appointments
8th Apr 202110:13 amGNWNet Asset Value(s)
1st Apr 202110:00 amGNWTotal voting rights and Capital
31st Mar 20215:01 pmGNWNet Asset Value(s)
25th Mar 20216:57 pmGNWNet Asset Value(s)
18th Mar 20215:22 pmGNWTransaction in Own Shares and Total Voting Rights
17th Mar 20214:26 pmGNWNet Asset Value(s)
17th Mar 202112:00 pmGNWIssue of supplementary prospectus
16th Mar 202110:18 amGNWNet Asset Value(s)
12th Mar 20215:51 pmGNWNet Asset Value(s)
8th Mar 202110:44 amGNWNet Asset Value(s)
1st Mar 202112:47 pmGNWTotal voting rights
25th Feb 20215:16 pmGNWTransaction in Own Shares and Total Voting Rights
24th Feb 202110:43 amGNWNet Asset Value(s)
17th Feb 20211:48 pmGNWNet Asset Value(s)
16th Feb 20214:30 pmGNWIssue of supplementary prospectus
10th Feb 202111:00 amGNWNet Asset Value(s)
10th Feb 202110:57 amGNWNet Asset Value(s)
9th Feb 20214:06 pmGNWNet Asset Value(s)
1st Feb 20212:24 pmGNWTotal voting rights and Capital
31st Jan 202112:41 pmGNWNet Asset Value(s)
21st Jan 20216:47 pmGNWTransaction in Own Shares and Total Voting Rights
20th Jan 20219:57 amGNWNet Asset Value(s)
15th Jan 20214:30 pmGNWIssue of Equity and Total Voting Rights
13th Jan 202110:30 amGNWNet Asset Value(s)
11th Jan 20213:06 pmGNWNet Asset Value(s)
8th Jan 20216:10 pmGNWNet Asset Value(s)
4th Jan 20211:03 pmGNWTotal voting rights
4th Jan 202110:50 amGNWNet Asset Value(s)
18th Dec 20203:04 pmGNWNet Asset Value(s)
10th Dec 20208:03 pmGNWTransaction in Own Shares and Total Voting Rights
10th Dec 20204:11 pmGNWCorrection: Issue of Equity and Total Voting Rights
10th Dec 20207:00 amGNWIssue of Equity and Total Voting Rights
9th Dec 20208:23 amGNWNet Asset Value(s)
7th Dec 20207:34 pmGNWNet Asset Value(s)
3rd Dec 202011:42 amGNWIssue of Supplementary Prospectus
1st Dec 20203:06 pmGNWTotal voting rights and Capital
30th Nov 20204:00 pmGNWClose of Offer to Further Applications
25th Nov 202010:40 amGNWNet Asset Value(s)
19th Nov 20204:21 pmGNWTransaction in Own Shares and Total Voting Rights
34567891011

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.